Literature DB >> 26767655

Outcomes of different concentrations of human amniotic fluid in a keratoconjunctivitis sicca-induced mouse model.

Guilherme G Quinto1,2, Juan Castro-Combs1, Li Li1, Navin Gupta1, Mauro Campos2, Ashley Behrens3,4.   

Abstract

To compare the effects of different concentrations of topical human amniotic fluid (HAF) in a mouse model of dry eye, forty C57BL/6 mice were divided into 4 treatment groups: 20 % HAF, 50 % HAF, 100 % HAF, and isotonic salt solution (control). Dry eye was induced by an injection of botulinum toxin B into the lacrimal gland. Tear production, ocular surface fluorescein staining, and blink rate were evaluated in each mouse at 5 time points during a 4-week period. Goblet cell density was assessed in stained histological sections. Regarding tear production, 20, 50, and 100 % HAF groups were all different from the control group (P < 0.001) at week 1. However, there were no statistically significant differences between the 20, 50, and 100 % HAF groups. At week 2, 20, 50, and 100 % HAF groups had significant improvement in staining score and were significantly different from the control group (P = 0.047, P = 0.005, and P = 0.001, respectively). No difference in spontaneous blink rate was observed between groups, at any time point. Goblet cell density was significantly decreased in the control group compared to the HAF treatment groups. All tested concentrations of topical HAF were effective and superior than the control in this keratoconjunctivitis sicca-induced mouse model. Further studies are needed to evaluate the effects of HAF on the human ocular surface.

Entities:  

Keywords:  Amniotic fluid; Dry eye; Mouse model; Treatment

Mesh:

Substances:

Year:  2016        PMID: 26767655     DOI: 10.1007/s10792-016-0180-0

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  30 in total

1.  Studies in fetal wound healing. V. A prolonged presence of hyaluronic acid characterizes fetal wound fluid.

Authors:  M T Longaker; E S Chiu; N S Adzick; M Stern; M R Harrison; R Stern
Journal:  Ann Surg       Date:  1991-04       Impact factor: 12.969

Review 2.  Tear dynamics and dry eye.

Authors:  K Tsubota
Journal:  Prog Retin Eye Res       Date:  1998-10       Impact factor: 21.198

3.  The mucin-deficient dry eye.

Authors:  M A Lemp
Journal:  Int Ophthalmol Clin       Date:  1973

4.  Effects of topical human amniotic fluid and human serum in a mouse model of keratoconjunctivitis sicca.

Authors:  Guilherme G Quinto; Walter Camacho; Juan Castro-Combs; Li Li; Suy Anne R Martins; Priscila Wittmann; Mauro Campos; Ashley Behrens
Journal:  Cornea       Date:  2012-04       Impact factor: 2.651

5.  Correlation of goblet cell density and mucosal epithelial membrane mucin expression with rose bengal staining in patients with ocular irritation.

Authors:  S C Pflugfelder; S C Tseng; K Yoshino; D Monroy; C Felix; B L Reis
Journal:  Ophthalmology       Date:  1997-02       Impact factor: 12.079

6.  The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study.

Authors:  Takashi Kojima; Reiko Ishida; Murat Dogru; Eiki Goto; Yukihiro Matsumoto; Minako Kaido; Kazuo Tsubota
Journal:  Am J Ophthalmol       Date:  2005-02       Impact factor: 5.258

7.  Dysfunctional tear syndrome: a Delphi approach to treatment recommendations.

Authors:  Ashley Behrens; John J Doyle; Lee Stern; Roy S Chuck; Peter J McDonnell; Dimitri T Azar; Harminder S Dua; Milton Hom; Paul M Karpecki; Peter R Laibson; Michael A Lemp; David M Meisler; Juan Murube Del Castillo; Terrence P O'Brien; Stephen C Pflugfelder; Maurizio Rolando; Oliver D Schein; Berthold Seitz; Scheffer C Tseng; Gysbert van Setten; Steven E Wilson; Samuel C Yiu
Journal:  Cornea       Date:  2006-09       Impact factor: 2.651

8.  Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.

Authors:  Olan Suwan-apichon; Michael Rizen; Ram Rangsin; Samantha Herretes; Johann M G Reyes; Kaevalin Lekhanont; Roy S Chuck
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-01       Impact factor: 4.799

9.  D-beta-hydroxybutyrate protects against corneal epithelial disorders in a rat dry eye model with jogging board.

Authors:  Shigeru Nakamura; Michiko Shibuya; Hideo Nakashima; Tomohiro Imagawa; Masato Uehara; Kazuo Tsubota
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-07       Impact factor: 4.799

Review 10.  Autologous serum eye drops for ocular surface disorders.

Authors:  G Geerling; S Maclennan; D Hartwig
Journal:  Br J Ophthalmol       Date:  2004-11       Impact factor: 4.638

View more
  1 in total

1.  Allogeneic Mesenchymal Stem Cell Transplantation in Dogs With Keratoconjunctivitis Sicca.

Authors:  Maura K W Bittencourt; Michele A Barros; João Flávio P Martins; Jose Paulo C Vasconcellos; Bruna P Morais; Celine Pompeia; Matheus Domingues Bittencourt; Karine Dos Santos Evangelho; Irina Kerkis; Cristiane V Wenceslau
Journal:  Cell Med       Date:  2016-10-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.